BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17962140)

  • 21. [Anemia as a risk factor for CKD and CVD].
    Tsuruya K; Hirakata H
    Nihon Rinsho; 2008 Sep; 66(9):1786-93. PubMed ID: 18788410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
    Pfeffer MA; Burdmann EA; Chen CY; Cooper ME; de Zeeuw D; Eckardt KU; Ivanovich P; Kewalramani R; Levey AS; Lewis EF; McGill J; McMurray JJ; Parfrey P; Parving HH; Remuzzi G; Singh AK; Solomon SD; Toto R; Uno H;
    Am J Kidney Dis; 2009 Jul; 54(1):59-69. PubMed ID: 19501439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: con.
    Himmelfarb J; Szczech LA
    J Am Soc Nephrol; 2009 Jul; 20(7):1441-3. PubMed ID: 19579287
    [No Abstract]   [Full Text] [Related]  

  • 24. Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: pro.
    Singh AK
    J Am Soc Nephrol; 2009 Jul; 20(7):1436-41. PubMed ID: 19579295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical approach to the diagnosis and treatment of anemia associated with CKD in elderly.
    Agarwal AK
    J Am Med Dir Assoc; 2006 Nov; 7(9 Suppl):S7-S12; quiz S17-21. PubMed ID: 17098634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics, cardiovascular comorbidity and medicines management in patients with type 2 diabetes and CKD: results of the IRIDIEM study.
    Stevens PE; Schernthaner G; Raptis S; Wanner C; Scherhag A; Lameire N
    Kidney Blood Press Res; 2010; 33(2):119-28. PubMed ID: 20424472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitude of physicians in Saudi Arabia towards anemia treatment strategies in patients with chronic kidney disease.
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):65-72. PubMed ID: 17237894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.
    Vaziri ND; Zhou XJ
    Nephrol Dial Transplant; 2009 Apr; 24(4):1082-8. PubMed ID: 18987263
    [No Abstract]   [Full Text] [Related]  

  • 29. The importance of early treatment of the anaemia of chronic kidney disease.
    Eknoyan G
    Nephrol Dial Transplant; 2001; 16 Suppl 5():45-9. PubMed ID: 11509684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure.
    Fishbane S; Miyawaki N
    Kidney Int; 2010 Feb; 77(3):175-7. PubMed ID: 20075952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treating anemia at different stages of renal disease.
    Locatelli F; Del Vecchio L; Pozzoni P
    J Nephrol; 2007; 20 Suppl 12():S33-8. PubMed ID: 18050140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical relevance of anemia treatment in patients with chronic kidney disease].
    Vuksanović-Mikulicić S; Mikolasević I; Jelić I; Bubić I; Sladoje-Martinović B; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):193-202. PubMed ID: 23441533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiorenal anemia syndrome (review)].
    Minasyan A
    Georgian Med News; 2012 Dec; (213):17-21. PubMed ID: 23293227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
    Dimković N
    Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and prevention of cardiovascular complication in chronic kidney disease patients.
    Pozzoni P; Pozzi M; Del Vecchio L; Locatelli F
    Semin Nephrol; 2004 Sep; 24(5):417-22. PubMed ID: 15490402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [What are the aims and targets of renal anemia therapy?].
    Eckardt KU
    Dtsch Med Wochenschr; 2007 Sep; 132(36):1837-41. PubMed ID: 17726657
    [No Abstract]   [Full Text] [Related]  

  • 38. Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?
    Vaziri ND
    Nat Clin Pract Nephrol; 2008 Aug; 4(8):436-45. PubMed ID: 18542121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anemia: the point of convergence or divergence for kidney disease and heart failure?
    Kazory A; Ross EA
    J Am Coll Cardiol; 2009 Feb; 53(8):639-47. PubMed ID: 19232895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemoglobin target in chronic kidney disease: a pediatric perspective.
    Keithi-Reddy SR; Singh AK
    Pediatr Nephrol; 2009 Mar; 24(3):431-4. PubMed ID: 18604563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.